| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $625.21M | - | |
| CEO | 296.8K | $7.14M | - | |
| Other | 282.8K | $6.80M | - | |
| Other | 216.6K | $5.21M | - | |
| Dir | 38.2K | $918.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2020 | Krognes Steve E.74 | CFO And Treasurer | Sell | 1,428 | $19.48 | $27,817.44 | -0.1% | |
| Mar 30, 2020 | Schuth Alexander O.75 | COO And Secretary | Sell | 1,427 | $19.49 | $27,812.23 | -4.7% | |
| Mar 30, 2020 | Ho Carole73 | Chief Medical Officer | Sell | 1,428 | $19.48 | $27,817.44 | -33.6% | |
| Mar 30, 2020 | Watts Ryan J.77 | President And CEO | Sell | 4,807 | $19.48 | $93,640.36 | -17.9% | |
| Feb 26, 2020 | Bratton Douglas K | 10% Owner | Sell | 3,894,764 | $20.25 | $78,868,971.00 | -20.0% | |
| Dec 23, 2019 | Ho Carole73 | Chief Medical Officer | Sell | 6,890 | $20.01 | $137,834.64 | -46.9% | |
| Dec 4, 2019 | Watts Ryan J.77 | President And CEO | Sell | 21,268 | $18.00 | $382,874.26 | -0.4% | |
| Dec 4, 2019 | Schuth Alexander O.75 | COO And Secretary | Sale+OE | 7,500 | $18.00 | $135,017.23 | -0.6% | |
| Nov 26, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 15,000 | $18.02 | $270,287.08 | -0.8% | |
| Nov 25, 2019 | Watts Ryan J.77 | President And CEO | Sell | 43,485 | $18.02 | $783,573.70 | -0.9% |